Financials
- Market Capitalization 20.38 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-0.42
주가매출액비율
207.27
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 4564 | LGVN Longeveron Inc. - Class A Common stock | 6.81 USD | +1.34% | +710.71% | +859.15% | +1092.02% | 21.71 M USD | ||
| 4573 | DYAI Dyadic International, Inc. - Common Stock | 0.56 USD | -8.20% | -20.00% | -46.15% | -38.46% | 20.41 M USD | ||
| 4578 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.43 USD | -2.52% | +30.87% | +38.88% | +1254.55% | 20.31 M USD | ||
| 4584 | ENLV Enlivex Ltd. - Ordinary Shares | 1.28 USD | -5.19% | -14.09% | -40.19% | +23.08% | 20.26 M USD |